Non-Acquired Panhypopituitarism

Watchlist

(log in to enable)

Retrieved

2021-01-23

Source

Orphanet

Trials

—

Genes

PROP1, SOX3, OTX2, GHRH, GNRH1, KISS1R, NR5A1, GNRHR, KISS1, CSHL1, POU1F1, TACR3, GLI2, FGFR1, FGF8, ZIC2, SIX3, PTCH1, SLC20A1, MAGEL2, SHH, SUFU, TDGF1, TGIF1, CDON, LHX3, DLL1, HESX1, PRL, FOXH1

PROP1, SOX3, OTX2, GHRH, GNRH1, KISS1R, NR5A1, GNRHR, KISS1, CSHL1, POU1F1, TACR3, GLI2, FGFR1, FGF8, ZIC2, SIX3, PTCH1, SLC20A1, MAGEL2, SHH, SUFU, TDGF1, TGIF1, CDON, LHX3, DLL1, HESX1, PRL, FOXH1, GLI3, GAS1, KIAA0556, GH1, LHX4, NODAL, DISP1, IGF1, BRD2, GHRHR, POMC, FOXA2, PAG1, HHIP, PROK2, RBM28, SMPD3, WDR11, PCBP4, SLC15A4, PROKR2, MIR511, ATP7B, ROBO1, KMT2B, MSH2, CD1A, CREBBP, EIF4E, GHR, GHSR, MSH6, ANOS1, SERPINA1, KMT2D, PITX2, OPN1LW, BMP4, S100A1, S100B, HNF1A, VIM, MIR593

Drugs

Leuprolide acetate ( LUPRON INJECTION )

Interested in hearing about new therapies?

A rare genetic pituitary disease characterized by variable deficiency of all hormones produced in the anterior lobe of the pituitary gland. Clinical manifestations include hypothyroidism, hypogonadism, growth retardation and short stature, and secondary adrenal insufficiency. Age of onset is variable. Signs and symptoms usually develop gradually, and loss of the different hormones is often sequential.